ReviewInternational urogynecology journal2025
Female Orgasmic Disorder: How Far We Have [Not] Come?
Review in International urogynecology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisThe female orgasm is a complex physiological and psychological response essential for sexual well-being and overall health. Historically misinterpreted, its significance is now better understood through modern research integrating neurobiological, hormonal, and psychological factors. Female orgasmic disorder (FOD), characterized by persistent difficulty in achieving orgasm, significantly affects emotional and relational well-being. This review summarizes current knowledge on the female orgasm, its dysfunction, and treatment modalities.
methodsA comprehensive literature search was conducted using MEDLINE/PubMed and Google Scholar, focusing on studies published between 2000 and 2024. Keywords included "female orgasmic disorder," "female orgasm," "anorgasmia," and "female sexual dysfunction." After screening abstracts and full texts, 20 articles were included, supplemented by additional sources through reference review.
resultsThe female orgasm involves interplay between anatomical structures such as the clitoris, vagina, and pelvic floor muscles, as well as neural pathways and hormonal interactions. FOD is classified as primary (lifelong) or secondary (acquired) and is influenced by psychosocial, relational, and medical factors. Treatment options include cognitive-behavioral therapy, directed masturbation, pelvic floor muscle training, pharmacological interventions such as sildenafil, bupropion, or hormonal therapy, mechanical devices, and emerging regenerative therapies such as platelet-rich plasma and stem cell treatments.
conclusionsUnderstanding the female orgasm and its dysfunction is essential for improving sexual health care. A biopsychosocial approach that integrates personalized, patient-centered treatments can enhance outcomes. Future research should focus on refining therapeutic strategies and expanding knowledge on novel interventions.
Indexed as
Identifiers
40586909What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.